{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T02:15:48Z","timestamp":1789697748743,"version":"4.0.1"},"reference-count":35,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2005,12,1]],"date-time":"2005-12-01T00:00:00Z","timestamp":1133395200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,12,1]],"date-time":"2005-12-01T00:00:00Z","timestamp":1133395200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2005,12]]},"DOI":"10.1016\/j.jneuroim.2005.08.018","type":"journal-article","created":{"date-parts":[[2005,10,4]],"date-time":"2005-10-04T14:22:59Z","timestamp":1128435779000},"page":"150-157","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":57,"title":["Functional characterisation of autoantibodies from patients with pediatric opsoclonus\u2013myoclonus-syndrome"],"prefix":"10.1016","volume":"170","author":[{"given":"Martina","family":"Korfei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Verena","family":"F\u00fchlhuber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Schmidt-W\u00f6ll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manfred","family":"Kaps","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus T.","family":"Preissner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franz","family":"Blaes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2005.08.018_bib1","first-page":"283","article-title":"Apoptotic retinal cell death induced by antirecoverin autoantibodies of cancer-associated retinopathy","volume":"38","author":"Adamus","year":"1997","journal-title":"Invest. Ophthalmol. Visual Sci."},{"key":"10.1016\/j.jneuroim.2005.08.018_bib2","first-page":"163","article-title":"Broken dogma: penetration of autoantibodies into living cells","volume":"17","author":"Alarcon-Segovia","year":"1996","journal-title":"Immunol. Today"},{"key":"10.1016\/j.jneuroim.2005.08.018_bib3","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1038\/3315","article-title":"Tumor-specific killer cells in paraneoplastic cerebellar degeneration","volume":"4","author":"Albert","year":"1998","journal-title":"Nat. Med."},{"key":"10.1016\/j.jneuroim.2005.08.018_bib4","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1002\/1097-0142(197602)37:2<846::AID-CNCR2820370233>3.0.CO;2-L","article-title":"Favorable prognosis for survival in children with coincident opso\u2013myoclonus and neuroblastoma","volume":"37","author":"Altman","year":"1976","journal-title":"Cancer"},{"key":"10.1016\/j.jneuroim.2005.08.018_bib5","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1097\/00005792-198803000-00003","article-title":"Opsoclonus, myoclonus, ataxia, and encephalopathy in adults with cancer: a distinct paraneoplastic syndrome","volume":"67","author":"Anderson","year":"1988","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jneuroim.2005.08.018_bib6","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/00043426-200007000-00007","article-title":"Antineuronal antibodies in patients with neuroblastoma and paraneoplastic opsoclonus\u2013myoclonus","volume":"22","author":"Antunes","year":"2000","journal-title":"J. Pediatr. Hematol.\/Oncol."},{"key":"10.1016\/j.jneuroim.2005.08.018_bib7","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1093\/brain\/124.2.437","article-title":"Clinical outcome in adult onset idiopathic or paraneoplastic opsoclonus\u2013myoclonus","volume":"124","author":"Bataller","year":"2001","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2005.08.018_bib8","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/ana.10462","article-title":"Autoantigen diversity in the opsoclonus\u2013myoclonus syndrome","volume":"53","author":"Bataller","year":"2003","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2005.08.018_bib9","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1002\/1531-8249(199902)45:2<162::AID-ANA5>3.0.CO;2-R","article-title":"Cell-mediated autoimmunity in paraneoplastic neurological syndromes with anti-Hu antibodies","volume":"45","author":"Benyahia","year":"1999","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2005.08.018_bib10","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1002\/1531-8249(200004)47:4<504::AID-ANA14>3.0.CO;2-Q","article-title":"IgG from \u201cseronegative\u201d myasthenia gravis patients binds to a muscle cell line, TE671, but not to human acetylcholine receptor","volume":"47","author":"Blaes","year":"2000","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2005.08.018_bib11","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0165-5728(89)90175-6","article-title":"Specificity of human anti-neurofilament autoantibodies","volume":"21","author":"Braxton","year":"1989","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2005.08.018_bib12","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1523\/JNEUROSCI.16-03-01114.1996","article-title":"The onconeural antigen Nova-1 is a neuron-specific RNA-binding protein, the activity of which is inhibited by paraneoplastic antibodies","volume":"16","author":"Buckanovich","year":"1996","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jneuroim.2005.08.018_bib13","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/S0022-3476(97)70272-5","article-title":"Serum autoantibodies in childhood opsoclonus\u2013myoclonus syndrome: an analysis of antigenic targets in neural tissues","volume":"130","author":"Connolly","year":"1997","journal-title":"J. Pediatr."},{"key":"10.1016\/j.jneuroim.2005.08.018_bib14","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1002\/mpo.1139","article-title":"Opsoclonus\u2013myoclonus\u2013ataxia syndrome in neuroblastoma: histopathologic features\u2014a report from the Children's Cancer Group","volume":"36","author":"Cooper","year":"2001","journal-title":"Med. Pediatr. Oncol."},{"key":"10.1016\/j.jneuroim.2005.08.018_bib15","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/S1474-4422(03)00374-0","article-title":"Childhood opsoclonus myoclonus","volume":"2","author":"Dale","year":"2003","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jneuroim.2005.08.018_bib16","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1212\/WNL.41.11.1757","article-title":"Detection of the anti-Hu antibody in specific regions of the nervous system and tumor from patients with paraneoplastic encephalomyelitis\/sensory neuronopathy","volume":"41","author":"Dalmau","year":"1991","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2005.08.018_bib19","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S0016-5085(03)00664-4","article-title":"Anti-HuD-induced neuronal apoptosis underlying paraneoplastic gut dysmotility","volume":"125","author":"De Giorgio","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jneuroim.2005.08.018_bib20","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1212\/WNL.43.10.2049","article-title":"Type IIa (\u2018anti-Hu\u2019) antineuronal antibodies produce destruction of rat cerebellar granule neurons in vitro","volume":"43","author":"Greenlee","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2005.08.018_bib21","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/ana.410130115","article-title":"Syndrome of opsoclonus\u2013myoclonus caused by Coxsackie B3 infection","volume":"13","author":"Kuban","year":"1983","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2005.08.018_bib22","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1093\/brain\/awh031","article-title":"Serum autoantibodies to cell surface determinants in multiple sclerosis: a flow cytometric study","volume":"127","author":"Lily","year":"2004","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2005.08.018_bib23","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/ana.410290303","article-title":"Anti-Ri: an antibody associated with paraneoplastic opsoclonus and breast cancer","volume":"29","author":"Luque","year":"1991","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2005.08.018_bib24","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0035-3787(04)70888-7","article-title":"Lambert\u2013Eaton myasthenic syndrome","volume":"160","author":"Newsom-Davis","year":"2004","journal-title":"Rev. Neurol. (Paris)"},{"key":"10.1016\/j.jneuroim.2005.08.018_bib25","doi-asserted-by":"crossref","first-page":"3012","DOI":"10.1200\/JCO.2000.18.16.3012","article-title":"Natural course of neuroblastoma detected by mass screening: s 5-year prospective study at a single institution","volume":"18","author":"Nishihira","year":"2000","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jneuroim.2005.08.018_bib26","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0165-5728(87)90088-9","article-title":"Anti-neurofilament protein antibodies in opsoclonus\u2013myoclonus","volume":"15","author":"Noetzel","year":"1987","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2005.08.018_bib27","doi-asserted-by":"crossref","first-page":"8328","DOI":"10.1073\/pnas.95.14.8328","article-title":"Human autoantibodies specific for the alpha1A calcium channel subunit reduce both P-type and Q-type calcium currents in cerebellar neurons","volume":"95","author":"Pinto","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jneuroim.2005.08.018_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00002826-199619010-00001","article-title":"The immunopharmacology of the opsoclonus\u2013myoclonus syndrome","volume":"19","author":"Pranzatelli","year":"1996","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.jneuroim.2005.08.018_bib29","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/S0887-8994(02)00457-5","article-title":"Screening for autoantibodies in children with opsoclonus\u2013myoclonus\u2013ataxia","volume":"27","author":"Pranzatelli","year":"2002","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.jneuroim.2005.08.018_bib30","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1212\/WNL.62.9.1526","article-title":"B- and T-cell markers in opsoclonus\u2013myoclonus syndrome: immunophenotyping of CSF lymphocytes","volume":"62","author":"Pranzatelli","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2005.08.018_bib31","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1002\/mds.20125","article-title":"CSF B-cell expansion in opsoclonus\u2013myoclonus syndrome: a biomarker of disease activity","volume":"19","author":"Pranzatelli","year":"2004","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jneuroim.2005.08.018_bib32","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1006\/jaut.1998.0219","article-title":"Cellular dysfunction induced by penetration of autoantibodies into living cells: cellular damage and dysfunction mediated by antibodies to dsDNA and ribosomal P proteins","volume":"11","author":"Reichlin","year":"1998","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jneuroim.2005.08.018_bib33","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1006\/jaut.2000.0454","article-title":"IgG-mediated cytotoxicity to myenteric plexus cultures in patients with paraneoplastic neurological syndromes","volume":"15","author":"Schafer","year":"2000","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jneuroim.2005.08.018_bib34","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S0022-510X(99)00163-X","article-title":"Cytotoxic T cells against a peptide of Yo protein in patients with paraneoplastic cerebellar degeneration and anti-Yo antibody","volume":"168","author":"Tanaka","year":"1999","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jneuroim.2005.08.018_bib35","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/S0165-5728(97)00124-0","article-title":"Paraneoplastic anti-Hu serum: studies on human tumor cell lines","volume":"79","author":"Verschuuren","year":"1997","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2005.08.018_bib36","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1172\/JCI119517","article-title":"Receptor-mediated cellular entry of nuclear localizing anti-DNA antibodies via myosin 1","volume":"100","author":"Yanase","year":"1997","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jneuroim.2005.08.018_bib37","doi-asserted-by":"crossref","first-page":"13254","DOI":"10.1073\/pnas.95.22.13254","article-title":"The neuronal RNA-binding protein Nova-2 is implicated as the autoantigen targeted in POMA patients with dementia","volume":"95","author":"Yang","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016557280500370X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016557280500370X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:02:45Z","timestamp":1759046565000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016557280500370X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,12]]},"references-count":35,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2005,12]]}},"alternative-id":["S016557280500370X"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2005.08.018","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2005,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Functional characterisation of autoantibodies from patients with pediatric opsoclonus\u2013myoclonus-syndrome","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2005.08.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}